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Abstract
Objective: To evaluate the spirometry values predicted by the 2012 Global Lung Function Initiative (GLI) 
equations, which are recommended for international use, in comparison with those obtained for a sample of 
White adults used for the establishment of reference equations for spirometry in Brazil. Methods: The sample 
comprised 270 and 373 healthy males and females, respectively. The mean differences between the values found 
in this sample and the predicted values calculated from the GLI equations for FVC, FEV1, and VEF1/FVC, as 
well as their lower limits, were compared by paired t-test. The predicted values by each pair of equations were 
compared in various combinations of age and height. Results: For the males in our study sample, the values 
obtained for all of the variables studied were significantly higher than those predicted by the GLI equations (p 
< 0.01 for all). These differences become more evident in subjects who were shorter in stature and older. For 
the females in our study sample, only the lower limit of the FEV1/FVC ratio was significantly higher than that 
predicted by the GLI equation. Conclusions: The predicted values suggested by the GLI equations for White 
adults were significantly lower than those used as reference values for males in Brazil. For both genders, the 
lower limit of the FEV1/FVC ratio is significantly lower than that predicted by the GLI equations. 
Keywords: Respiratory function tests/statistics and numerical data; Respiratory function tests/diagnosis; 
Reference values.
Resumo
Objetivo: Comparar os valores espirométricos previstos pelas equações da Global Lung Function Initiative (GLI) 
em 2012, sugeridas como de uso internacional, com aqueles obtidos em uma amostra utilizada para derivação 
de valores de referência em adultos caucasianos brasileiros. Métodos: A amostra utilizada era composta por 
270 homens e 373 mulheres saudáveis. As médias das diferenças entre os valores dessa amostra e os valores 
previstos calculados a partir das equações da GLI para CVF, VEF1 e VEF1/CVF, assim como seus limites inferiores, 
foram comparados por teste de t pareado. Os valores previstos pelos pares das equações foram comparados em 
diversas combinações de idade e estatura. Resultados: Nos homens da amostra, os valores obtidos para todas as 
variáveis estudadas foram significativamente maiores que aqueles previstos pelas equações da GLI (p < 0,01 para 
todas). Estas diferenças se tornaram mais evidentes em indivíduos com menor estatura e idade mais avançada. 
Nas mulheres, somente o limite inferior da relação VEF1/CVF foi significativamente maior na amostra brasileira. 
Conclusões: Os valores previstos sugeridos pelas equações da GLI para caucasianos são significativamente 
menores daqueles utilizados como referência para homens brasileiros. Em ambos os sexos, o limite inferior da 
relação VEF1/CVF é significativamente menor que o previsto pelas equações GLI 
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Introduction
The interpretation of pulmonary function 
tests is based on comparisons between data 
obtained for an individual patient and (predicted) 
reference values derived from healthy subjects. 
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acknowledge that the included data from Latin 
America are scarce and that that equation should 
not be used in the continent.
However, values for White adults were 
suggested, and we tested the hypothesis that 
those values could fit our population.
Methods
The predicted values derived from the ERS 
Global Lung Function Initiative (GLI) equations(19,21) 
for White adults were calculated for males and 
females by using data on gender, height, and 
age found in a study of reference values for the 
Brazilian population.(16) The patients selected 
completed a standard respiratory questionnaire,(22) 
were nonsmokers, had no respiratory symptoms, 
and had no cardiopulmonary disease. The Brazilian 
sample included 270 males (age, 25-86 years; 
height, 152-192 cm) and 373 females (age, 20-85 
years; height, 137-182 cm).
The equations derived for males were as 
follows(16):
FVC = H × 0.0517 − A × 0.0207 – 3.18 
(lower limit of normality [LLN] = −0.90)
FEV1 = H × 0.0338 − A × 0.0252 – 0.789 
(LLN = −0.76)
FEV1/FVC × 100 = 120.3 − H × 0.175 − A × 
0.197 (LLN = −7.6)
where H is height in cm and A is age in years.
The equations derived for females were as 
follows(16): 
FVC = H × 0.041 − A × 0.0189 – 2.848 
(LLN = −0.64)
FEV1 = H × 0.0314 − A × 0.0203 – 1.353 
(LLN = −0.61)
FEV1/FVC × 100 = 111.5− H × 0.140 − A × 
0.158 (LLN = −8.3)
The GLI equation used to derive the parameter 
values is as follows:
log(Y) = 5a + b × log(H) + c × log(A) + AS + 
d × group
where Y is the dependent variable, H is height 
in cm, A is age in years, and AS is age spline.
Ideally, reference values should be derived from a 
population similar to that tested, using appropriate 
equipment and following standard procedures.(1)
Pulmonary function values differ substantially 
among different regions of the world, which has 
been attributed to anthropometric, environmental, 
social, and genetic factors, as well as to technical 
factors.(1-4) Attempts to compile equations by 
different authors were made for Europe in 1983(5) 
and again in 1993.(6) Those recommendations of 
the work group were accepted and made official 
by the European Respiratory Society (ERS), which 
supported their widespread use in Europe.
In 2005, a joint guideline of the American 
Thoracic Society (ATS) and the ERS recommended 
that the equations derived in the Third National 
Health and Nutrition Examination Survey (NHANES 
III) be adopted in the USA, but it did not endorse 
the use of equations for Europe, recommending 
that new reference values be obtained.(1) The 
latter recommendation was based on the fact 
that the derivation of reference values for 
spirometry in various European countries after 
1993 demonstrated that the equations proposed by 
Quanjer et al. underestimated predicted values. (6-10) 
This finding was confirmed by various studies 
published after 2005.(11-15) Similar results were 
observed when reference values derived for the 
Brazilian population were compared with those 
proposed by Quanjer et al.(6,16,17)
Various limitations were identified in the 
derivation of the equations that were compiled 
by that group of authors, and it was suggested 
that those reference values be abandoned,(18) 
although studies using those reference values 
continue to be published.
In 2012, an even bolder proposal was suggested 
by Quanjer et al.: the derivation of universal 
equations.(19) Data on reference values derived 
from 72 centers in 33 countries were provided for 
the derivation of the equations. In Latin America, 
values derived in the Projeto Latino-Americano de 
Investigação em Obstrução Pulmonar (PLATINO, 
Latin American Project for the Investigation 
of Obstructive Lung Disease), which included 
subjects over 40 years of age, were provided.(20) 
We decided not to send the equations derived 
for adults in the Brazilian population because of 
the limitations observed in the previous study by 
Quanjer et al.6) and because we do not believe 
that a universal pulmonary function equation is 
possible. The proponents of the universal equation 
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In the present study, universal reference 
equations for spirometry proved unable to predict 
spirometry values in the Brazilian population 
accurately.
Various reference value equations have been 
published in recent decades. The expected values 
for individuals with a certain combination of age 
and height can differ considerably.(1-3)
Such variations can be explained by the criteria 
used for selecting ‘normal’ populations, by the 
equipment used, by the measurement techniques, 
by the biological variability of populations, by 
socioeconomic and environmental factors, and by 
the statistical models used in the data analysis.
In 2005, the ATS and ERS published a joint 
guideline on pulmonary function.(1) Reference 
values were suggested for children and adults 
in the United States; however, values for other 
places remained to be established. As a result of 
this lack of recommendation, a group of authors, 
led by Quanjer, founded the GLI in Berlin in 2008. 
In April of 2010, the group received, as occurred 
previously,(5,6) the seal of the ERS as a task force.
(19) In 2012, values derived from data sent from 
various places were grouped, as occurred with 
European data in 1993,(6) and reference values 
for subjects aged 3-95 years were suggested. 
In total, 74,187 nonsmokers from 26 countries 
in five continents were included in equations 
derived by combining various studies. The data 
relating to South America, which were derived 
from a study conducted in Latin America(20) and 
from a sample of children in Mexico,(23) were 
disregarded because of differences in height and 
in predicted values, as well as because of the lack 
of data for subjects aged 25-40 years. However, 
according to the published supplement, 178 
cases of White adults in Brazil were included.(19)
The values for White adults were derived 
especially from five large studies: two conducted 
in the United States(24,25) and three conducted in 
Europe.(7,10,13) It is of note that the values derived 
in those studies differ, which was attributed to 
the different equipment used. However, various 
factors, such as sample selection, measurement 
techniques, and quality control, also influence 
the results obtained, which complicates the 
aggregation of different studies.
Comparing the values calculated from the GLI 
equation with the data derived from a sample 
used for the establishment of reference equations 
Group takes a value of 1 for White adults, 
and this value was used in the present study. The 
Brazilian equation for FVC and FEV1 is linear:
Y = a × H − b × A – constant
The mean values found in the Brazilian sample 
for FVC, FEV1, and FEV1/FVC, as well as their 
lower limits, were compared with the predicted 
values calculated from the GLI equations on 
the basis of the age and height of individual 
subjects in the Brazilian sample. Paired t-test 
was used for the comparisons.
Subsequently, on the basis of the Brazilian 
values, a linear regression analysis was performed 
between age (independent variable) and height 
(dependent variable). Regression equations were 
used to calculate the expected value for height 
at ages 25, 50, and 75 years for both genders. 
The values calculated from the GLI equation and 
those calculated from the Brazilian equation were 
tabulated and compared in various combinations 
of age and height.
All statistical procedures were performed with 
the IBM SPSS Statistics software, version 20.0 
(IBM Corp., Armonk, NY, USA).
Results
The mean differences between the predicted 
values calculated from the Brazilian equations 
and those generated by the GLI equations, as well 
as their lower limits, are shown in Table 1. For 
males, the values found in the Brazilian sample 
for all of the variables studied were significantly 
higher than those generated by the GLI equations. 
For females, there were practically no differences, 
except for the lower limit of the FEV1/FVC ratio, 
for which the values in the Brazilian sample 
were significantly higher than those generated 
by the GLI equations.
When the data tabulated for the various 
combinations of age and height were compared, 
additional data could be observed (Tables 2 and 
3). For males, the differences were more evident 
in shorter, older subjects. In subjects aged 75 
years, the differences for FVC and for its lower 
limit were 0.36 L and 0.38 L, respectively. For 
these same subjects, the difference for FEV1 and 
for its lower limit was 0.29 L for both.
It is also of note that the FEV1/FVC ratio was 
lower as calculated from the GLI equation, with 
the difference increasing with age.
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lower with the use of the GLI equations, given 
that the lower limit of the FEV1/FVC ratio as 
calculated from these equations is significantly 
lower, especially in older subjects.
The differences between the predicted values 
calculated from the GLI equation for the FEV1/
FVC ratio and its lower limits vary because of 
the regression model used; however, they are, on 
average, 0.11 for males and 0.12 for females,(21) 
which exceeds the values derived in Brazil (0.08 
for males and 0.09 for females).(16)
Recent studies have compared spirometric 
diagnosis by the equation suggested by the GLI 
for spirometry in Brazil,(16) we found that, for 
males, the use of the GLI equation results in 
lower values both in terms of predicted values 
and of their lower limits. For females, the values 
are quite similar, except for the FEV1/FVC ratio 
and its lower limit, for which the values in the 
Brazilian sample are higher than those generated 
by the GLI equation. These findings indicate that 
the use of the GLI equation will fail to diagnose 
reductions in FVC and, therefore, will have lower 
sensitivity in detecting obstructive lung disease 
in males. For both genders, the sensitivity for 
the diagnosis of obstructive lung disease will be 
Table 1 - Mean differences for the variables studied, calculated by subtracting the predicted values found 




Δ t p Δ t p
FVC 0.29 ± 0.62 7.81 < 0.001 −0.01 ± 0.38 −0.75 0.46
LL 0.30 ± 0.59 9.41 < 0.001 0.01 ± 0.38 0.65 0.52
FEV1 0.28 ± 0.50 9.06 < 0.001 0.00 ± 0.33 0.36 0.72
LL 0.29 ± 0.48 10.12 < 0.001 −0.02 ± 0.33 −0.93 0.36
FEV1/FVC 0.93 ± 4.89 3.14 0.002 0.02 ± 5.00 0.06 0.95
LL 3.27 ± 4.71 11.43 < 0.001 3.68 ± 5.23 13.55 < 0.001
LL: lower limit. aValues expressed as mean ± SD.
Table 2 - Predicted spirometry values for the Brazilian 
population(16) and those generated by the Global Lung 
Function Initiative (GLI) equation(19,21) for combinations 








FVC, L 25 175 5.35 5.18
50 170 4.58 4.48
75 165 3.80 3.44
LL 25 175 4.45 4.19
50 170 3.68 3.50
75 165 2.90 2.52
FEV1, L 25 175 4.50 4.35
50 170 3.69 3.56
75 165 2.90 2.61
LL 25 175 3.74 3.51
50 170 2.93 2.78
75 165 2.14 1.85
FEV1/FVC 25 175 0.85 0.85
50 170 0.81 0.80
75 165 0.77 0.76
LL 25 175 0.77 0.73
50 170 0.73 0.69
75 165 0.69 0.62
LL: lower limit.
Table 3 - Comparison between predicted spirometry 
values for the Brazilian population(16) and those generated 
by the Global Lung Function Initiative (GLI) equation(19,21) 








FVC, L 25 162 3.82 3.84
50 158 3.18 3.24
75 153 2.47 2.31
LL 25 162 3.18 3.07
50 158 2.54 2.53
75 153 1.83 1.63
FEV1, L 25 162 3.23 3.30
50 158 2.60 2.60
75 153 1.90 1.79
LL 25 162 2.62 2.65
50 158 1.93 2.03
75 153 1.32 1.28
FEV1/FVC 25 162 0.85 0.87
50 158 0.81 0.81
75 153 0.78 0.78
LL 25 162 0.77 0.75
50 158 0.73 0.70
75 158 0.68 0.64
LL: lower limit.
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and by other equations. One study compared 
spirometric diagnosis by three equations in 17,572 
tests (subjects aged 18-85 years) performed in 
laboratories in Australia and Poland.(26) The 
values calculated from the equations derived 
by the GLI were higher than those calculated 
from the equations derived by Quanjer et al.,(6) as 
expected. Differences in the lower limits resulted 
in a significant reduction in the diagnosis of 
restrictive lung disease when the GLI equation 
was compared with the NHANES III equation, 
although the latter was incorporated into the 
GLI equation (but comprised less than 4% of 
the sample). In males, restrictive lung disease 
was diagnosed in 22.6% by the NHANES III 
equation and in 17.1% by the GLI equation. In 
females, the proportions were 22.8% and 8.1%, 
respectively.
In a study conducted in Tunisia, local predicted 
values and those suggested by the GLI were used 
in 1,192 consecutive spirometries in adults aged 
18-60 years.(27) Again, the proportion of cases 
diagnosed with restrictive lung disease by the 
use of the local equation (19.0%) was greater 
than that diagnosed by the GLI equation (8.4%).
The findings of the aforementioned studies 
are not surprising, given the wide range for 
determination of lower limits by the GLI equation, 
which is the result of the combination of several 
equations for which quality control and results 
were different.
In conclusion, the values suggested by the 
multiethnic reference equation proposed by the 
GLI, developed for White adults, differ significantly 
from the values derived for White adult males 
in Brazil. For females, the values derived are 
similar for FVC, FEV1, and their lower limits. For 
both genders, the lower limit of the FEV1/FVC 
ratio is significantly lower as calculated from 
the GLI equation.
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